You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic prostate cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))

Recruiting
  • Prostate Cancer
  • Hyperpolarized Pyruvate (13C)
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 4, 2022

Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022

Circulating Tumor Cells in High Risk and Early Metastatic

Recruiting
  • High Risk Prostate Carcinoma
  • +3 more
  • Blood collection
  • Bala-Cynwyd, Pennsylvania
  • +1 more
Jun 28, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

High Risk Prostate Carcinoma Trial in Gyeonggi-do, Seoul, Soeul ([F-18]Florastamin)

Recruiting
  • High Risk Prostate Carcinoma
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jun 29, 2023

Preferences for Treatment of mPC in Hong Kong:Discrete Choice

Recruiting
  • Prostate Cancer
    • Sha Tin, Hong Kong
      Prince of Wales Hospital
    Mar 14, 2023

    Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco

    Recruiting
    • Prostate Cancer
    • +2 more
    • Consultation audio recording app
    • San Francisco, California
      University of California, San Francisco
    Jul 27, 2022

    Genetic Testing for Men With Metastatic Prostate Cancer

    Recruiting
    • Metastatic Prostate Carcinoma
    • +2 more
    • Biospecimen Collection
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 9, 2022

    Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

    Enrolling by invitation
    • Prostate Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    to DIrect the manaGement of Metastatic Prostate Cancer

    Recruiting
    • Metastatic Prostate Cancer
      • London, United Kingdom
        University College London Hospital
      Jan 6, 2022

      Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • (no location specified)
      Jun 15, 2023

      Metastatic Prostate Cancer Trial in Salt Lake City (dietary supplement, other, behavioral)

      Not yet recruiting
      • Metastatic Prostate Cancer
      • creatine monohydrate
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Oct 30, 2023

      Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

      Not yet recruiting
      • Metastatic Hormone-Sensitive Prostate Cancer
      • (no location specified)
      Nov 10, 2023

      Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

      Not yet recruiting
      • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      • Sipuleucel-T Injection
      • (no location specified)
      Nov 10, 2023

      Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial (Patient Navigation,

      Not yet recruiting
      • Metastatic Prostate Carcinoma
      • +2 more
      • Patient Navigation
      • +3 more
      • (no location specified)
      Aug 2, 2022

      Metastatic Prostate Cancer Trial in Birmingham ([68Ga]PSMA-PET/MRI or PET/CT)

      Completed
      • Metastatic Prostate Cancer
      • [68Ga]PSMA-PET/MRI or PET/CT
      • Birmingham, Alabama
        University of Alabama at Birmingham Medical Center
      Mar 7, 2022

      Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

      Active, not recruiting
      • Metastatic Prostatic Adenocarcinoma
      • Charleston, South Carolina
        Medical University of South Carolina
      Jan 30, 2023

      Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

      Recruiting
      • Metastatic Prostate Cancer
      • Badalona, Spain
      • +8 more
      Jan 18, 2023

      Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

      Not yet recruiting
      • Prostate Cancer
      • Baltimore, Maryland
        Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
      Sep 22, 2023

      Prostate Cancer, Metabolic Syndrome, Obesity Trial (Apple Cider Vinegar, Placebo)

      Not yet recruiting
      • Prostate Cancer
      • +6 more
      • Apple Cider Vinegar
      • Placebo
      • (no location specified)
      Mar 24, 2023

      Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

      Not yet recruiting
      • Prostatic Neoplasms
      • Metastatic Castration-Resistant Prostate Cancer
      • (no location specified)
      Oct 23, 2023

      Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

      Completed
      Has Results
      • Prostate Cancer
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 23, 2022

      Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

      Recruiting
      • Prostate Cancer
      • Prostate Cancer Metastatic
      • La Jolla, California
      • +1 more
      Feb 2, 2023

      Metastatic Prostate Cancer Trial in New York (MR-Guided Prostate SBRT)

      Recruiting
      • Metastatic Prostate Cancer
      • MR-Guided Prostate SBRT
      • New York, New York
        Weill Cornell Medicine
      Oct 29, 2021

      Prostate Cancer, Prostate Cancer Metastatic Trial in Dallas (68Ga PSMA-11 injection, Positron Emission Tomography/Computed

      Recruiting
      • Prostate Cancer
      • Prostate Cancer Metastatic
      • 68Ga PSMA-11 injection
      • Positron Emission Tomography/Computed Tomography
      • Dallas, Texas
        UT Southwestern Medical Center
      Jan 21, 2022